Washington, D.C. (August 17, 2017)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, and Rep.
Washington, DC - Yesterday, the House of Representatives approved Rep. Peter Welch’s amendment to prohibit the Pentagon from using taxpayer dollars to purchase uniforms for Afghan National Army.
WASHINGTON - Rep. Peter Welch (D-VT), joined by Rep.
WASHINGTON – Rep. Peter Welch and House colleagues representing districts along the U.S. Canadian border have introduced the Northern Border Regional Commission Reauthorization Act of 2017, which would reauthorize the Northern Border Regional Commission (NBRC) for five years.
WASHINGTON –Reps. Peter Welch (D-VT) and Tom Reed (R-NY) today introduced the Smart Manufacturing Leadership Act which would help small and medium-sized American manufacturers adopt smart manufacturing technologies.
Washington, D.C.– At a Capitol Hill press conference this morning, Rep. Peter Welch and nine House colleagues unveiled a five-part plan to improve the Affordable Care Act (ACA). The plan, Solutions Over Politics, would stabilize the individual insurance marketplace where insurance premiums have skyrocketed and some insurers have ceased participation.
WASHINGTON – U.S. Senators Chris Coons (D-Del.), Bill Cassidy, MD (R-Louis.), John Barrasso (R-Wyo.), and Michael Bennet (D-Colo.) and U.S.
WASHINGTON—Today, Rep. Peter Welch (D-VT) and House colleagues on the Bipartisan Task Force to Combat the Heroin Epidemic unveiled their legislative agenda to battle the opioid epidemic ravaging communities in Vermont and across the country.
WASHINGTON— Reps. Peter Welch (D-VT) and John Katko (R-NY) today introduced bipartisan legislation to help federal student loan borrowers make smarter loan choices and better position themselves during the repayment process. The bill is the latest Welch initiative to simplify the process of applying for and repaying federal student loans.
Washington, DC – Rep. Peter Welch (D-VT) and Rep. Elijah Cummings (D-MD) sent a letter to President Trump in reaction to press reports that he will soon sign an executive order favorable to the agenda of the pharmaceutical industry that will provide no relief to Americans reeling from exorbitant drug price increases.